Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapiesMuhammad A. Alvi, Manuel Salto‐Tellez, Richard Turkington et al.|British Journal of Cancer|2017Cited by 57